M1A.45 Other secondary chronic gout, hip

Name of the Condition

• Other Secondary Chronic Gout, Hip

Summary

Other secondary chronic gout, hip is a form of arthritis affecting the hip joint, resulting from elevated uric acid levels due to an identifiable underlying condition or cause. It leads to recurrent joint inflammation and potential tissue damage, with symptoms that may persist over time. Advanced stages can involve the formation of tophi (urate crystal deposits) in the hip area.

Causes

Other secondary chronic gout, hip arises from an underlying condition that disrupts uric acid metabolism, causing accumulation in the blood. This can stem from overproduction of uric acid or reduced renal clearance due to factors like chronic kidney disease, certain medications, or hematologic disorders. Over time, urate crystals deposit in the hip joint and surrounding tissues, triggering inflammation.

Risk Factors

• Underlying conditions that affect uric acid metabolism (e.g., certain hematologic disorders, enzyme deficiencies)
• Medications that increase uric acid levels (e.g., some diuretics, chemotherapy agents)
• Chronic kidney disease or renal impairment
• History of gout or hyperuricemia
• Exposure to substances that disrupt uric acid excretion

Symptoms

• Recurrent episodes of intense hip pain, often with swelling and redness
• Persistent warmth and tenderness in the hip joint
• Stiffness and limited range of motion in the hip
• Formation of tophi (hard, painless lumps) around the hip area
• Flare-ups triggered by stress, diet, or illness

Diagnosis

Diagnosis involves a combination of clinical evaluation, patient history, and laboratory tests. Joint fluid analysis may confirm the presence of urate crystals. Imaging studies, such as X-rays or ultrasound, can assess joint damage or tophi. Underlying conditions contributing to uric acid elevation are also investigated.

Treatment Options

Treatment focuses on managing symptoms, reducing uric acid levels, and addressing the underlying cause. Medications may include nonsteroidal anti-inflammatory drugs (NSAIDs), colchicine, or corticosteroids for acute flares. Long-term management often involves urate-lowering therapies like allopurinol or febuxostat. Lifestyle modifications, such as dietary changes, may also be recommended.

Prognosis and Follow-Up

With proper management, symptoms can be controlled, and joint damage may be minimized. Regular follow-up is important to monitor uric acid levels, adjust medications, and address any complications. Untreated or poorly managed cases may lead to progressive joint damage or tophi formation.

Complications

• Chronic joint damage or deformity
• Formation of tophi in the hip or surrounding tissues
• Increased risk of kidney stones or renal impairment
• Reduced mobility and quality of life

Lifestyle & Prevention

• Maintain a healthy weight and balanced diet
• Limit alcohol and high-purine foods (e.g., red meat, seafood)
• Stay hydrated to support uric acid excretion
• Follow prescribed medication regimens consistently
• Avoid triggers known to provoke flare-ups

When to Seek Professional Help

Seek medical attention if you experience sudden, severe hip pain, swelling, or redness, or if symptoms persist despite home care. Prompt evaluation is important to prevent joint damage and manage underlying conditions.

Tips for Medical Coders

Document the hip as the specific site of involvement. Ensure the underlying cause of secondary gout is clearly identified and coded separately if applicable. Verify that the diagnosis aligns with clinical findings and laboratory results to support accurate coding.